牛牛AI助理已提取核心訊息
Merck & Co. Inc. officer Joseph Romanelli is set to sell 1,000 shares of common stock on 02/13/2024, as announced in a recent filing. The shares, which have an aggregate market value of $124,887.90, were originally acquired on 05/04/2014 through restricted stock vesting under a registered plan. The transaction will be executed nearly a decade after the securities were obtained directly from the issuer. No other sales of securities have been reported by Romanelli in the past three months.
Merck & Co. Inc. officer Joseph Romanelli is set to sell 1,000 shares of common stock on 02/13/2024, as announced in a recent filing. The shares, which have an aggregate market value of $124,887.90, were originally acquired on 05/04/2014 through restricted stock vesting under a registered plan. The transaction will be executed nearly a decade after the securities were obtained directly from the issuer. No other sales of securities have been reported by Romanelli in the past three months.
默沙東公司正如在最近的一份文件中宣佈的那樣，公司高管約瑟夫·羅曼內利定於2024年2月13日出售1,000股普通股。這些股票的總市值爲124,887.90美元，最初是在2014年4月5日通過註冊計劃通過限制性股票歸屬收購的。該交易將在直接從發行人那裏獲得證券近十年後執行。在過去的三個月中，羅曼內利沒有報告其他證券銷售情況。
默沙東公司正如在最近的一份文件中宣佈的那樣，公司高管約瑟夫·羅曼內利定於2024年2月13日出售1,000股普通股。這些股票的總市值爲124,887.90美元，最初是在2014年4月5日通過註冊計劃通過限制性股票歸屬收購的。該交易將在直接從發行人那裏獲得證券近十年後執行。在過去的三個月中，羅曼內利沒有報告其他證券銷售情況。
有用
沒用